Selected article for: "age distribution and respiratory disease"

Author: Julien Riou; Anthony Hauser; Michel J Counotte; Christian L Althaus
Title: Adjusted age-specific case fatality ratio during the COVID-19 epidemic in Hubei, China, January and February 2020
  • Document date: 2020_3_6
  • ID: mrsya6wz_20
    Snippet: Among infected individuals with symptoms, which is more relevant to the clinical situation, adjusted mortality is estimated at 3.6% (95%CrI: 3.1-4.1). Under 20 years of age, mortality among symptomatics is estimated below 1 in 1,000 and rises to between 3 to 8 per 1,000 symptomatic infections for individuals aged 20 to 49 years. Mortality among symptomatics is estimated to 2.5% (95%CrI: 1.9-3.1) among individuals aged 50-59, 8.0% (95%CrI: 6.6-9.5.....
    Document: Among infected individuals with symptoms, which is more relevant to the clinical situation, adjusted mortality is estimated at 3.6% (95%CrI: 3.1-4.1). Under 20 years of age, mortality among symptomatics is estimated below 1 in 1,000 and rises to between 3 to 8 per 1,000 symptomatic infections for individuals aged 20 to 49 years. Mortality among symptomatics is estimated to 2.5% (95%CrI: 1.9-3.1) among individuals aged 50-59, 8.0% (95%CrI: 6.6-9.5) among individuals aged 60-69, 19 .2% (95%CrI: 15.8-22.9) among individuals aged 70-79 and reaches 39.0% (95%CrI: 31.1-48.9) among individuals aged 80 and more. The estimated prevalence of the four comorbidities is shown in Figure 3C . Compared with the expected prevalence given the age-distribution of deaths associated with SARS-CoV-2 infection, we observe a higher proportion of patients with diabetes and a lower proportion with chronic respiratory disease or hypertension among Covid-19 deaths in Hubei

    Search related documents:
    Co phrase search for related documents